Sanofi Files 6-K with June Press Releases
Ticker: SNYNF · Form: 6-K · Filed: Jul 2, 2024 · CIK: 1121404
| Field | Detail |
|---|---|
| Company | Sanofi (SNYNF) |
| Form Type | 6-K |
| Filed Date | Jul 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, press-release, international-operations, healthcare
TL;DR
Sanofi dropped a 6-K with June pressers - Africa polio vax and ISTH updates.
AI Summary
Sanofi filed a Form 6-K on July 2, 2024, incorporating four press releases from June 2024. These include a press release dated June 20, 2024, detailing Sanofi's collaboration with Biovac to enhance polio vaccine manufacturing in Africa, and another dated June 21, 2024, related to the ISTH conference.
Why It Matters
This filing provides updates on Sanofi's strategic initiatives, including its role in African vaccine manufacturing and its participation in significant medical conferences.
Risk Assessment
Risk Level: low — This filing is an informational report and does not contain new financial data or material events that would significantly impact the company's risk profile.
Key Players & Entities
- Sanofi (company) — Registrant
- Biovac (company) — Partner in polio vaccine manufacturing initiative
- June 20, 2024 (date) — Date of press release regarding polio vaccine manufacturing
- June 21, 2024 (date) — Date of press release regarding ISTH
- July 2, 2024 (date) — Filing date of the 6-K
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information that Sanofi has made or is required to make public in France or to its security holders, specifically by incorporating press releases issued in June 2024.
Which specific press releases are incorporated into this filing?
This filing incorporates press releases dated June 20, 2024 (Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa) and June 21, 2024 (ISTH: Sanofi).
What is the significance of the press release dated June 20, 2024?
The press release dated June 20, 2024, highlights Sanofi's collaboration with Biovac to enhance polio vaccine manufacturing capabilities in Africa.
What is the filing date of this Form 6-K?
This Form 6-K was filed on July 2, 2024.
What is Sanofi's principal executive office address?
Sanofi's principal executive offices are located at 46, avenue de la Grande Armée, 75017 Paris, France.
Filing Stats: 253 words · 1 min read · ~1 pages · Grade level 11.7 · Accepted 2024-07-02 14:25:26
Filing Documents
- d627610d6k.htm (6-K) — 10KB
- d627610dex991.htm (EX-99.1) — 16KB
- d627610dex992.htm (EX-99.2) — 37KB
- d627610dex993.htm (EX-99.3) — 12KB
- d627610dex994.htm (EX-99.4) — 33KB
- g627610dsp4.jpg (GRAPHIC) — 2KB
- g627610g0702163606954.jpg (GRAPHIC) — 3KB
- g627610g0702163620479.jpg (GRAPHIC) — 3KB
- g627610g0702163630780.jpg (GRAPHIC) — 3KB
- g627610g0702163647475.jpg (GRAPHIC) — 3KB
- 0001193125-24-174204.txt ( ) — 127KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: July 2, 2024 SANOFI By /s/ Alexandra Roger Name: Alexandra Roger Title: Head of Legal Corporate & Finance 3